<DOC>
	<DOC>NCT00971308</DOC>
	<brief_summary>The purpose of this study is to determine the antiviral effect following three days of dosing with BMS-824393 in chronically genotype subtype 1a and 1b Hepatitis C virus (HCV) infected subjects.</brief_summary>
	<brief_title>Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<criteria>Treatment naive chronically infected subjects with Hepatitis C Virus genotype 1 HCV RNA viral load of ≤10*5* IU/mL (100,000 IU/mL) Body Mass Index (BMI) of 18 to 35 kg/m², inclusive Women who are pregnant or breast feeding Any significant acute or chronic medical illness which is not stable or is not controlled with medication or is not consistent with Hepatitis C infection Any other medical, psychiatric and/or social reason which, in the opinion of the Investigator, would make the candidate inappropriate for participation in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>